LightPath Technologies Inc (LPTH) 2020 Q4 法說會逐字稿

完整原文

使用警語:中文譯文來源為 Google 翻譯,僅供參考,實際內容請以英文原文為主

  • Operator

  • Good afternoon. And welcome to the LightPath Technologies Fiscal Fourth Quarter and Year-End 2020 Financial Results Conference Call. (Operator Instructions) Please also note, today's event is being recorded. I will now pass the call off to Don Retreage, Chief Financial Officer of LightPath Technologies. Please go ahead.

  • Donald O'connor Retreage - Senior VP & CFO

  • Good afternoon. Before we get started, I would like to remind you that during the course of this conference call, the company will be making a number of forward-looking statements that are based on current expectations and involve various risks and uncertainties that are discussed in this periodic SEC filing. Although the company believes that the assumptions underlying these statements are reasonable, any of them can prove to be inaccurate, and therefore, there can be no assurance that the results would be realized. In addition, references may be made to certain non-generally accepted accounting principles or non-GAAP measures, for which you should refer to the appropriate disclaimers and reconciliations in the company's SEC filings and press releases. Following management discussion, there will be a formal Q&A session open to participants on the call. I would now like to turn the conference over to Sam Rubin, LightPath's President and Chief Executive Officer. Sam, please go ahead.

  • Shmuel Rubin - President, CEO & Director

  • Thank you, and good afternoon. Welcome to LightPath's Technologies' Fiscal 2020 Fourth Quarter Financial Results Conference Call. Our financial results press release was issued after the market close today and posted to our corporate website. Following my remarks, our CFO, Donald Retreage, will further review our financial results and provide more perspective on key areas. We will then conduct a Q&A session.

  • Now on to my remarks. Our fiscal 2020 fourth quarter and full year fiscal -- full year results reflect a consistent and continuing improvement and growth of our business, while at the same time, navigating the dynamic and changing conditions caused by the effects of COVID-19 to our business, our customers and our supply chain. Classified as an essential business, we remained open and operating to the extent possible. We continue to take all precautions to ensure that our employees remain safe and that our business operations continue. Through it all, we're very encouraged to have ended the year by delivering growth in revenue, backlog, gross margin, gross profit, net income, EBITDA and the cash balance, while reducing our total debt and financial lease balance and improving our cost structure with a reduction in operating expenses. All of this was achieved despite nearly 6 months of the fiscal year being impacted by COVID-19.

  • Similar to our results in the previous quarters, our fourth quarter results continue to show consistent improvement year-over-year and consistent results throughout our fiscal year. The gross margin for the quarter ended at 39%, up from 32% in Q4 2019, while the EBITDA margin grew to 19%, up from negative 3 the same period the previous year. These results reflect savings from the integration of the ISP acquisition and other efficiency-related activities as well as the favorable product mix in our PMO business. Additionally, our backlog grew to $19.1 million, up from $17.1 million at the end of fiscal 2019, but down from $20 million the previous quarter. The sequential decline in backlog is attributed primarily to the annual blanket order from our largest customer, which typically is renewed in our fiscal second quarter ending December 31.

  • While the 4% growth in revenue year-over-year is definitely a positive outcome, our actual shipments during the quarter varied compared to plan due to unexpectedly scheduling requests by some customers as a consequence of the impact of COVID-19. As we had mentioned in earlier communications over the last few months, we have been capacity constrained in some parts of our business since February, primarily due to the demand from 5G infrastructure deployment, a trend that we see continuing. We have been addressing those capacity constraints through the use of overtime, through acceleration of investments in production equipment, and through careful scheduling and planning of our production capacity to address all sales orders, requiring a very focused effort on both our internal and external supply chain. However, due to COVID-19, some customers have experienced either fluctuating demand or some unexpected impact to their operations or other parts of their supply chain.

  • Given the nature of the manufacturing process and the added complexity of being capacity-constrained, our manufacturing schedule cannot always adjust fast enough to such unexpected changes, leading to temporary increase in our inventory as seen in our inventory levels growing to $8.9 million.

  • While we strive to be agile and adjust quickly to changes in demand, we expect for some of these variations to continue in the coming months until demand and supply chain return to a steady state. In parallel to navigating the COVID-19-impacted economy and supply chain, our team has worked on developing a new strategic direction for LightPath, that was initiated following my appointment as CEO in March 2020. This strategy has now been developed and is one based on our strengths and our core capabilities to address the largest and fastest-growing trends in our industry for visible and infrared optics.

  • I'd now like to discuss some key elements of this strategy. First, addressing the broad, diversified photonics market. We're going to lead the efforts, we capitalize on optics as an enabling technology. We recognize that the opportunity for optics and optical assemblies has changed over the past several years. Now optics, or more generally photonics and optical technologies, are increasingly pervasive across industries and markets. Optics is not an industry vertical in itself, as an enabling technology, which spans industries well beyond telecommunication, for which we're seemingly known. Optics is a key technology in industries from automotive, defense, medical, surveillance, industrial equipment, telecommunication and consumer products, just to name a few. All of which are industries we already serve. As such, the market opportunity for what we do at LightPath is enormous and global, and is constantly expanding as other industries and companies find applications for optics in their products and industry.

  • Second, we're going to be focusing on our competitive anchors, including our differentiated design capabilities, molding IP, variety of manufacturing technologies and low-cost vertically integrated global manufacturing. We will prioritize our efforts around the differentiation we bring to the market and our customers and others that others cannot offer, and we will constantly seek to add to those capabilities as needed.

  • Third, we will be centered around continuous improvement through operational excellence, leading to margin and profitability optimization and strengthening of our overall financial position. This will encompass both short-term and long-term initiatives throughout the organization and be supported by a culture which values results and accountability.

  • Fourth, we will make investments that improve capacity and factory flow efficiency, engineering expertise and leverage our human capital. We will make the necessary investments in our people to enable our strategy with world-class optical design and engineering talent, including a sales force that can focus and prioritize customer opportunities which supports our strategic goals.

  • Finally, and perhaps most important strategic directive, is to mobilize around the integrated solutions orientation for high-value customers. In doing so, we will leverage our expertise to focus on client opportunities that are in line with our new strategic direction and ultimately improve our financial performance. We will leverage our unique capability using our expertise in optical design and manufacturing to create solutions for customers rather than components. Over time, this will promote a richer business model supported by longer-term partnership with our customers. In the coming weeks, we will begin a comprehensive alignment of the organization to our new strategic direction, including a view of our capabilities, structure, processes and all other aspects required for our team to be positioned to execute on this direction. Some of those opportunities for improvement and operational excellence have already been identified shortly after I joined the company. And we began executing upon them immediately. One such area, for example, includes our cash management, where through the implementation of metaprocesses and controls, we have been able to increase our cash position to $5.4 million, while at the same time, continuing to invest in capacity expansion, while utilizing our line of credit for financial flexibility, and reducing our total debt and operating lease obligations.

  • Strategic priorities evolve, and this is the beginning of the process. LightPath will change the operations and execution culture to be best-in-class, and we will choose the highest value OEM customers and business opportunities to invest in. The enhanced approach will provide even more value to our customers, great opportunities to our employees and better financial returns to our shareholders. As we continue to implement operational improvements throughout our organization and fully execute on the outcomes of our comprehensive strategic review, we expect both near-term and long-term impacts towards further improving on our growth and key financial indicators beyond what we have achieved to date. Now I'll pass the call over to our CFO, Don Retreage, to provide more details on some of the other aspects of our fourth quarter and full year 2020 financial results. Don, please?

  • Donald O'connor Retreage - Senior VP & CFO

  • Thank you, Sam. First, I would like to mention and remind all that much about the information we are discussing during this call is also included in the press release issued earlier today and in our 10-K filed with the SEC. I encourage you to visit our website at LightPath.com and specifically the section titled Investor Relations.

  • Now on to my remarks pertaining to the fourth quarter and year-end fiscal 2020. Sam's remark covered some of our financial performance, along with key elements of our strategic direction. So I will be specifically discussing key financial areas.

  • Revenue for the first quarter of fiscal 2020 was approximately $9.1 million, up from $8.7 million in both third quarter and fourth quarter 2019 -- third quarter 2020, sorry, and fourth quarter 2019. For the year, revenues were $35 million, up from $33.7 million in fiscal 2019. IR product revenue was $4.8 million in Q4 2020 or 53% of total revenue, up from $4.3 million or 50% in the third quarter 2020 and $4.7 million or 54% of the total in the prior year period.

  • Visual precision -- visible precision molded optics, or PMO products, revenue in fourth quarter '20 was $3.9 million or 43% of the total, same as third quarter 2020 or 44% of the total in third quarter 2020 and $3.5 million or 40% of the total in the fourth quarter 2019. For the year, IR product revenues were $18.1 million or 52% of the total, up 5% from about $17.2 million or 51% of the total in the fiscal 2019. PMO revenues were $14.6 million or 42% of the total in fiscal 2020 and up 4% from about $14 million or 42% of the total prior year. Demands of our revenue for the fourth quarter and full year respective periods were from specialty products -- specialty products and nonrecurring engineering projects, which vary greatly from quarter-to-quarter, were a substantially small contributors to the consolidated revenue. With respect to our margin profile, generally speaking, PMO products are small and almost entirely molded. So we have faster turnaround times, higher volume applications and more automated processing.

  • These products are also generally low in price. We historically have had margins averaging in the 40% to 50% range. This group represents about 42% of our total revenue in fiscal 2020. You can see that of the 2 primary segments, PMO is the small group with the higher margin. The IR product group represents a larger and faster-growing market opportunity. IR margins have historically been in the 20% to 35% range with our new molded IR lenses, which use our proprietary internally developed BD6 material on the top side, if not able to go higher with efficiencies.

  • As part of our gross margin improvement strategies, we have been aggressively working at marketing new products and targeting new customers using line of innovative BD6, while attempting to convert existing customers to the extent possible from using our germanium lenses for BD6 lenses.

  • Moving on. Gross margin in the fourth quarter of fiscal 2020 was $3.5 million, an increase of 24% as compared to approximately $2.8 million in the same quarter of prior fiscal year. Total cost of sales was $5.6 million for the fourth quarter 2020, down from $5.9 million in the prior year. Lower total cost of sales is meaningful when you consider that the total sales increased 4%. Gross margin as a percentage of revenue was 39% for the fourth quarter 2020, as compared to 32% in the fourth quarter 2019. The increase in gross margin came down as a percentage of revenues in primarily -- is primarily driven by the increase in sales and an improved cost structure, along with elimination of elevated costs, including labor, manufacturing inefficiencies and increased overhead expenses associated with the relocation of our New York facility in the prior year period. For the year, gross margin for fiscal 2020 was $13.8 million, an increase of 11% from $12.5 million in fiscal 2019. The total cost of sales was approximately $21.1 million in fiscal 2020, slightly lower than $21.2 million in the prior year. Gross margin as a percentage of revenue was 40% for the 2020 compared to 37% for fiscal 2019. The increase in gross margin reflects the changes to our cost structure, as well as improvements made in the second, third and fourth quarters of fiscal 2020 after several factors negatively impacted the first quarter of fiscal 2020.

  • As in the fiscal third quarter, demand in aggregate had been strong. Although there are packets of weakness that emerge as followed from COVID-19, which includes, as Sam mentioned, the delivery and processing challenges, we continue to enjoy strong demand from secular or long-term market applications, including 5G. For this product, we believe we could have had a large order flow if we had not been capacity constrained. Additional capacity has been added, and we are accelerating certain buildouts.

  • Our production volumes are growing. In the fourth quarter 2020, we produced 1.2 million lenses, up from 904,000 lenses in Q3 of 2020. 868,000 lenses made in second quarter 2020. Unit volumes sold in the fourth quarter of 2020 was up 62% as compared to the fourth quarter of fiscal 2019 and up 41% year-on-year. The total units sold in 2020 was $3.6 million, up from $2.6 million last year.

  • During the fourth quarter of fiscal 2020, total operating expenses was approximately $2.9 million, a decrease of $1 million or nearly 26% as compared to $3.9 million in the same period of the prior fiscal year. The largest reduction came from SG&A, which decreased from about $900,000, on new product development, which decreased about $117,000. The change from the prior year reflects the elimination of nonrecurring expenses from last year, which are related to the relocation of the New York facility as well as other reduced personnel and overhead cost from synergies. And to a lesser extent, limited travel and marketing expenses from COVID-19 restrictions. The product development expense variation reflects shifting of personnel to newly created product management function, which is also in our selling, general and administrative expenses. For the full year, total operating expenses in 2020 was $11.7 million, down $2 million or about 15% from $13.7 million in 2019. SG&A was down $1.5 million, and product development were down $300,000 for reasons similar to the changes in the fourth quarter. It should also be noted that expenses in the third quarter was reduced by gains on disposal of equipment of approximately $136,000, which is masking some of the savings when compared to total 2020 expenses.

  • Our consolidated corporate income tax in the U.S. is shielded by our net operating loss carryforward benefits of approximately $74 million at June 30, 2020. But we do have to pay income tax in the countries of certain foreign subsidiaries. Income tax expense for the fourth quarter of fiscal 2019 included the reversal of $406,000 of income tax benefits recorded in the first half of fiscal 2019 due to the change in company's estimated utilization of U.S. net operating loss carryforward benefits for 2019. During the fourth quarter of fiscal 2020, the company recorded income tax expense of $90,000 as compared to $496,000 in the same period of the prior fiscal year. During the fiscal 2020, the company recorded income tax expenses of $764,000, primarily related to the income tax from operations in China and Chinese withholding tax associated with the intercompany dividend.

  • With the higher revenues, strong margin, management of expenses and lower income tax, net income for the fourth quarter of fiscal 2020 was $657,000 compared to a net loss of $1.8 million for the fourth quarter of fiscal 2019, which was negatively impacted by elevated costs, including labor, cost, manufacturing inefficiencies and increased overhead expenses associated with the relocation of the company's New York facilities. We are operating far more efficiently and profitably, having completed that transition, improved our cost structure and increased revenue margins. Net income for the year was $867,000, up from a net loss of $2.7 million.

  • Moving to the balance sheet and cash flow-related items, capital expenditures, including equipment, financed through leases, was $938,000 in the fourth quarter 2020 and $2.4 million for the year, up from $326,000 and $2.5 million, respectively, in the prior periods. Given that we have been running at near capacity, we intend to continue to invest similarly in 2021. Meanwhile, net cash provided by operations was $3.7 million for fiscal 2020, up from $411,000 in prior year, with fourth quarter 2020, contributing $1.8 million or about 49% of the full year amount.

  • Total debt, including finance leases, was reduced by approximately $650,000 or 10% in fiscal 2020 from June 30, 2019. Our cash balance at June 30, 2020, was $5.4 million, up from $4.6 million at June 30, 2019. As of June 30, 2020, LightPath's 12-month backlog was $19.1 million, an increase of 11% from $17.1 million as of June 30, 2019. It should be noted that this is natural for a -- that it is natural for our backlog to fluctuate during the year as a result of the timing of such bookings of large orders and annual renewals. The company has also undisclosed backlog of beyond 12 months.

  • On a final note, through the increase of our share price and market value, we're pleased to have been added to the Russell Microcap Index effect with the annual reconstitution on June 29, 2020. With this review of our financial highlights and recent developments concluded, I will turn the call over to the operator so that we may begin with question-and-answer session.

  • Operator

  • (Operator Instructions) Our first question comes from Marc Wiesenberger with B. Riley FBR.

  • Marc Wiesenberger - Associate

  • Yes. Very nice execution in the quarter. Currently, I think you have capacity to produce around 3 million molded lenses per year. Can you talk about the growth trajectory around the molded capacity and where you'd expect to deploy that capacity from a geographic perspective?

  • Shmuel Rubin - President, CEO & Director

  • Yes. Our capacity has definitely been growing in the last few months as we've been investing and accelerating some of the investments in our manufacturing equipment. To remind, we -- in the previous quarter, we stated that we're going to expedite some of those investments, which we have, and which have come into effect during the last quarter and towards the end of the quarter. That's evident in the growth of our molded lenses where we produced $1.2 million in the last quarter, which is a 33% growth compared to the quarter before that, third first quarter. Some of the investments of those molding machines and equipment are in our China facility, some of them are in our U.S. facility. Other part of the investment is the target of where we make the investments and where we need to expand capacity changes over time, some of those investments are going to be in our facility in Riga as well as additional investments in the U.S.

  • Marc Wiesenberger - Associate

  • Great. Can you talk a little bit more about the progress of BD6 adoption from new customers, substitution from existing customers, your goals for BD6 in -- from your product portfolio and then the resulting financial implications we should see in FY '21?

  • Shmuel Rubin - President, CEO & Director

  • Definitely. The results from this transition to BD6 are very encouraging as we stand right now. By nature, the type of orders for BD6 versus germanium or altogether for thermal imaging, such that takes a long time to mature and to go from design to prototyping to actual production. One example is a large contract that we announced a few months ago, and that only in the near future, we're going to start shipping on that contract. And that contract alone has still taken quite a while to reach. We have a strong pipeline of opportunities. Some of them is a quoting process, many of them in the design process in which we work very closely with the customer and some of them in the prototyping process. We believe that we have some significant wins coming down the road. Most of them will start shipping within 6 months or so after we get the orders. Some of them might be shorter, some of them might be longer.

  • Marc Wiesenberger - Associate

  • Sure. You talked about solid 5G demand from China. What other geographies are you seeing that are maybe starting to accelerate and have deployments? And can you talk about these other markets outside of China?

  • Shmuel Rubin - President, CEO & Director

  • Yes. We provide our 5G lenses into the transceiver manufacturers and transponder manufacturers. Most of them are in Asia. And by the nature of it and by the structure of the supply chain, except for Chinese manufacturers where we know, that they are vertically integrated, and when we sell the lenses to them, we know that they make the end equipment. With other customers, we do not always know where the transceivers end in terms of geographical distribution. We do know that we supplied the lenses into multiple manufacturers of 5G equipment and optical transceivers in such a variety that we know that we're definitely not concentrated at one country or another in terms of the deployment of the 5G. But do not have the full information as to the geographical deployment of this.

  • Marc Wiesenberger - Associate

  • Sure. Understood. And then last one for me. I think you talked about the emerging use cases for optics and photonics which will require supplementary technologies. Can you talk about how LightPath's positioned to meet those additional demands?

  • Shmuel Rubin - President, CEO & Director

  • Absolutely. And part of the organization alignment that we're going to do, first of all, now, but really the ongoing efforts that will happen over the next few years. It's going to be -- continuously look at such opportunities and see what supplemental product or technologies or capabilities we need in order to support them. This could be a situation where a customer is buying our lens and/or a customer's working with us on their complete solution, and their solution also includes, say, a scanning mirror, which is their electronic component that moves the beam around, and we could be integrating that. It could be much -- something much closer to home, which we've already done a couple of times, integrating the detector and actively aligning the entire optical system to deliver really a complete closed and hermetically sealed even, optical system to the customer. By nature of it, optics being, going into so many different applications in so many places, the type of other components or other technologies that are needed would vary drastically from one customer to another. And as we go along, we're going to see which ones make sense for us, where can we create real value to customers.

  • Operator

  • The next question is from Gene Inger with ingerletter.com.

  • Gene Inger - Research Analyst

  • Sam and Don, congratulations on navigating through the pandemic so far and keeping the company constantly operating. And forgive my sore throat, but I'll try to ask a couple of questions that Riley didn't touch on. You've basically covered it, Sam, by discussing expanding beyond what some believe are relatively low-margin commodity lenses, although you've already increased the margins on those. So a good job with that. You just mentioned a moment ago -- you just mentioned integrated optics, which caused me to think of your colleagues and neighbors over at Luminar. I don't know that they're going public affects you directly, but as they expand do you foresee a standard relationship? Or would you rather not talk about potential colleagues or customers?

  • Shmuel Rubin - President, CEO & Director

  • Thank you, Gene. It's good to hear your voice, and thank you for the question. First of all, I'll start by congratulating our neighbor Luminar for going public and joining us from NASDAQ. It's always nice to have neighbors in the neighborhood share with us the stock exchange. We have a good relationship with many customers. And with many customers, we explore whatever value can we create to them. Where is it that we can do more for them? And what are their needs? We cannot comment on specific customers for the most part, but we definitely look closely at the LIDAR marketplace and work with multiple companies developing different LIDAR solutions at many different levels. Some of them, we discuss assemblies, some of them we discuss individual components with. It's obvious that LIDAR is going to become a major application for optics in the future. We cannot know and tell which company will win the LIDAR race. So the best thing we can do is work with as many companies as we can and support them by creating some value for them either through our knowledge of optical engineering, by creating individual components of assemblies that will enhance their products.

  • Gene Inger - Research Analyst

  • That is what I assume you meant by integrated optics, and I was really a little bit excited to look forward to many of these things that are forthcoming. I also wanted to...

  • Shmuel Rubin - President, CEO & Director

  • So am I.

  • Gene Inger - Research Analyst

  • I wanted to inquire, with regard to China, your subsidiaries there are wholly owned, where I think in the past, there was a large fund out of Shanghai, Pudong that was an investor. I'm assuming that is now retired. And the Chinese government does not have a problem with you operating as a wholly owned operation?

  • Shmuel Rubin - President, CEO & Director

  • That's correct. We -- both companies are wholly owned by us, 100%. We have 100% control of ours. We do not -- we're not limited by any regulatory requirement related to our Chinese subsidiary by any of the countries or any of the sites related to that. And this is very similar to the experience I had in the 6 years I spent in China, setting up and building from scratch, a large company there. A WOFE, as it's called, a wholly owned foreign entity, is completely owned and controlled by the foreign mother company, and that's exactly the case, LightPath, with our 2 subsidiaries there.

  • Gene Inger - Research Analyst

  • I'm glad to hear that. Could you also expand? Lately, there is more tension between China and India and companies like Ceragon, which is Israeli, with wireless backhaul has benefited. And because they do a lot of business in India with Vodafone. And I'm just wondering whether India barring Huawei because of the tensions between them actually works to your benefit with vertical integration in China, if I assume much of what you make in China is sold to Huawei or other networking companies in the country?

  • Shmuel Rubin - President, CEO & Director

  • Yes. We don't have much direct sales into India. And as mentioned in our previous comments, we often do not know the end-use of our product since we're sometimes 2 or 3 layers removed from the end product. So in this case, the only insight I might have is really no insight in a sense of none of our business has been affected by any of that to our knowledge, and we don't see an impact from that.

  • Gene Inger - Research Analyst

  • Glad to hear that. And my last question would just be Ciena's CEO, a couple of weeks back, when they made their numbers for the second quarter, but he gave pretty sloppy guidance going forward, and he talked about many of their customers in Photonics. Lumentum is one. I think you deal with some of those customers, and that may be what you're reflecting when you're saying your customers rescheduling deliveries. But it sounds like there's a lot of orders that aren't canceled, but they're simply pushed into the future. So isn't that giving an impression, I hope, that things are looking favorable as we adjust to the new normal and migrate into the third and fourth quarters?

  • Shmuel Rubin - President, CEO & Director

  • Yes. We definitely meant exactly that, that orders are being pushed out due to, most of the time, logistical constraints. And if I would give one example, we have one customer that has production line in 3 different facilities, and one facility had to close down. Those other 2 facilities cannot pick up the entire capacity and hence, 1/3 of the deliveries to them would get delayed until that facility reopened, in that one example. So most of those are similar to that in that sense. The other unexpected factors are affecting the supply chain of the operations, and we're being asked to delay or hold off on the shipments. If it's with enough notice, we can halt production and move that capacity to use something else. If it's not, we hold it in inventory.

  • Gene Inger - Research Analyst

  • Well it sounds promising. And if anything, you had a good quarter, the EBITDA was great and you did this despite these impediments with the pandemic. So I'm looking forward to good growth and welcome your leadership and hope things go well.

  • Shmuel Rubin - President, CEO & Director

  • Thank you. I appreciate it, Gene. Have a good day.

  • Operator

  • (Operator Instructions) Our next question is from Chris Wachowski, a private investor.

  • Unidentified Participant

  • Congratulations on a great quarter.

  • Shmuel Rubin - President, CEO & Director

  • Thank you.

  • Unidentified Participant

  • So regarding the 5G visible optics, molded lenses, I'm not sure if I passed your statements correctly, but it seems like you're saying that there's pending demand even outside of your backlog. That is, if you tell your customers that they're holding back some orders and if you tell them that you have more capacity, you'll get more orders. Is that correct?

  • Shmuel Rubin - President, CEO & Director

  • Yes. You understood it correctly.

  • Unidentified Participant

  • All right. That's good to hear. And about those lenses, again, the 5G lenses. Now as data rates increase, the optics have to be more precise. And are you getting certain price increases on your lenses? And does that cause a bit of the increase in the gross margin? How is the pricing going?

  • Shmuel Rubin - President, CEO & Director

  • Don, do you want to?

  • Donald O'connor Retreage - Senior VP & CFO

  • The prices? In general, yes. However, all -- formally in the past it's been to give discounts on higher volume because we had different reasons. Obviously, now at full capacity, those levels are leveled out. So there won't be any great price decreases aside from what the market is demanding. So we do not foresee erosion of the price in the PMO lenses to affect us far more in the next 2 or 3 quarters.

  • Unidentified Participant

  • All right. That's great to hear. And regarding your strategic realignment, should we be looking forward to noticeably higher SG&A costs because of that in the future?

  • Shmuel Rubin - President, CEO & Director

  • Yes, that's a great question. And we've been very disciplined in both our growth and expenses on new capabilities, on new manpower as well as our capital investments where we need discipline to finance all of that through our own cash flow generated and being aware of profit margins or total EBITDA margins as we grow the business. And we intend to continue that and be, as much as possible, in line with what we've been doing until now. That said, there might be required here and there some individual expenses on adding 1 or 2 specific skills by form of people or some unique equipment that might be a bit different than take somewhat longer to see the return. But we do not expect that to be significantly different.

  • Unidentified Participant

  • All right. That's good to hear. It's about time we started making some real profits here. And yes. Another question. So about those temporary pushouts, can you just give us a feel as to what you're experiencing now in August and September, and is that -- are you less affected now than you were in the past quarter?

  • Shmuel Rubin - President, CEO & Director

  • I'd say it's still ongoing, as I noted in my remarks, and we continue -- we believe it will continue to be somewhat ongoing until things stabilize. In most cases, it moves, I'd say, sort of between one customer and another. It's not one specific customer that keeps pushing out and so on, except for maybe one or 2 cases. But for the most part, it's -- we see it sort of as a transitioning between different geographical areas where it happens, different customers in different industries and different periods. We try, as I mentioned, to be as agile as possible and to be on top of it. But given that we're running at capacity or capacity constrained, at least in the molding part of the business, and sometimes, the supply chain and the time to turn around orders is long, there's sometimes not much we can do about it, and we just end up preparing a bit more inventory than we care for.

  • Unidentified Participant

  • Okay. I understand that. Well that's it for me.

  • Operator

  • We show no additional questions at this time. So I'd like to turn the conference back over to Mr. Rubin for any closing remarks.

  • Shmuel Rubin - President, CEO & Director

  • Thank you for participating in today's call. Before we conclude, I wanted to thank Jim Gaynor, my predecessor, for the 13 years of service as the CEO of LightPath and extend our best wishes to Jim and his family on his retirement. We look forward to speaking with you next quarter. Until then, we will be participating at the Sidoti & Company Fall Virtual Investor Conference on September 23 and have been invited to speak at the MicroCap Club's Virtual Leadership Summit on September 25. Thank you again, and goodbye.

  • Operator

  • The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.